187 results on '"Burock, Susen"'
Search Results
2. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
3. Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
4. Dissecting the genetic heterogeneity of gastric cancer
5. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
6. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker
7. Pharmacovigilance of Local Chemotherapy in the Peritoneum
8. Self-collected oral, nasal and saliva samples yield sensitivity comparable to professionally collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients
9. The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
10. Klassische Zytostatika-Gruppierungen
11. Pharmakokinetik, Pharmakodynamik, Interaktionen und Dosismodifikationen
12. Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January-March 2021
13. Support of a molecular tumour board by an evidence-based decision management system for precision oncology
14. Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy
15. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
16. Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study
17. Isolierte Extremitätenperfusion bei Weichgewebesarkomen
18. Profile of the Multicenter Cohort of the German Cancer Consortium’s Clinical Communication Platform
19. Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials
20. Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
21. A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2
22. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
23. Academia–Industry Partnerships: Are we ready for new models of partnership?: The point of view of the EORTC, an academic clinical cancer research organisation
24. Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study
25. Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients
26. Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival
27. SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests
28. Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test
29. Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer
30. Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
31. The dream and reality of histology agnostic cancer clinical trials
32. Abstract 2879: MACC1 overexpression in colorectal cancer is driven by chromosomal instability and is associated with molecular subtype
33. SARS-CoV-2 variant of concern B.1.1.7: diagnostic accuracy of three antigen-detecting rapid tests
34. Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021
35. Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis
36. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasalversusnasopharyngeal swab
37. SARS-CoV-2 patient self-testing with an antigen-detecting rapid test: a head-to-head comparison with professional testing
38. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab
39. Epidemiology, prevalence, and prognosis of multiple malignancies of a subpopulation of a large German cancer center.
40. DURTRERAD: A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab and tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative HNSCC—Results of the preplanned feasibility interim analysis.
41. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer
42. Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance program
43. Abstract 2000: Cancer metastasis driven by the novel MEK1 substrate MACC1 is restricted by clinically applicable MEK1 inhibitors
44. Phenotypic and functional characteristics of patient derived murine xenograft models.
45. Characteristics of cancer patients with a history of solid organ transplantation: Analysis of a patient cohort reporting to a large cancer center.
46. A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients: The RAMTAS trial of the German AIO (KRK-0316).
47. Clinical impact of comprehensive versus targeted genomic analysis for precision oncology.
48. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society
49. Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study
50. Successful generation of patient derived xenografts and patient derived 3D cultures as preclinical models for breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.